EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CDK4/6 Inhibition Induces CD8 + T Cell Antitumor Immunity via MIF‐Induced Functional Orchestration of Tumor‐Associated Macrophages

Lin He iD, Yuzhong Peng, Lat-Lun Leong, Jingbo Zhou, Dongyang Tang, Weilu Wang, Xiaoran Wu, Josh Haipeng Lei, Yongqin Ye, Yangyang Feng, Yunfeng Qiao, Xiangpeng Chu und 6 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202511330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Lin He und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Cyclin-Dependent Kinase 6, Cyclin-Dependent Kinase 4, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China (NSFC), Chair Professor Grant (CPG), University of Macau Multiyear Grant (MYRG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclin‐dependent kinases 4 and 6 (CDK4/6) regulate cell cycle progression from the G 1 to S phase. Recently, CDK4/6 inhibition (CDK4/6i) is demonstrated to enhance antitumor immunity, as evidenced by increased tumor infiltration of CD8 + T cells; however, the mechanism underlying this phenomenon remains unclear. This study reveals that CDK4/6i enhances intratumoral CD8 + T cell infiltration in breast tumors through functional reprogramming of tumor‐associated macrophages (TAMs), facilitating indirect interactions between tumor and CD8 + T cells. Mechanistically, CDK4/6i enhances the accumulation and activation of M1 TAMs and promotes the M2 to M1 polarization via augmented interaction of the macrophage migration inhibitory factor (MIF)‐CD44/CD74 axis between tumor cells and macrophages. CDK4/6i drives tumor cells to secrete MIF by activating the HIF‐1α pathway. CDK4/6i‐trained M1 TAMs increase the population of CD8 + T cells and activate them through the MHC‐I antigen presentation machinery. Inhibition of MIF or loss of Mif in tumor cells reverses the immunostimulatory effects of CDK4/6i on macrophages and subsequent CD8 + T cell antitumor immunity. Therefore, CDK4/6i‐trained M1 TAM supernatant therapy surmounts the immunosuppressive tumor microenvironment and induces a tumor response to low‐dose PD‐1 immune checkpoint blockade therapy in breast cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor-Associated MacrophagesCyclin-Dependent Kinase 6Cyclin-Dependent Kinase 4CD8-Positive T-LymphocytesMacrophage Migration-Inhibitory FactorsIntramolecular OxidoreductasesBreast NeoplasmsAnimalsFemaleMiceHumansTumor MicroenvironmentCell Line, Tumor

Stichwörter der Autor:innen

CD8+ T cellCDK4/6 inhibitorcell–cell communicationtumor immune microenvironmenttumor‐associated macrophage

Substanzen

Cyclin-Dependent Kinase 6Cyclin-Dependent Kinase 4Macrophage Migration-Inhibitory FactorsIntramolecular OxidoreductasesMif protein, mouseCDK6 protein, human

Autor:innen und Institutionen

  • Cancer Center, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
  • Center for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
  • MOE Frontier Science Center for Precision Oncology, University of Macau, Macau SAR, 999078, China.
  • Medical Sciences Division, Macau University of Science and Technology, Macau SAR, 999078, China.
  • Precision Regenerative Medicine Research Centre, Macau University of Science and Technology, Macau SAR, 999078, China.
  • University Hospital, Macau University of Science and Technology, Macau SAR, 999078, China.

ORCID-Profile: Lin He, Chu-Xia Deng

Förderung

  • Natural Science Foundation of China (NSFC)
  • Chair Professor Grant (CPG)
  • University of Macau Multiyear Grant (MYRG)
  • Macao Science and Technology Development Fund
  • Fundo para o Desenvolvimento das Ciências e da Tecnologia

Zitieren

APA

He, L., Peng, Y., Leong, L. L., Zhou, J., Tang, D., Wang, W., Wu, X., Haipeng Lei, J., Ye, Y., Feng, Y., Qiao, Y., Chu, X., Mu, D., Zhao, Q., Liu, T., Chen, Y., Tam, P. K., & Deng, C. X. (2026). CDK4/6 Inhibition Induces CD8 + T Cell Antitumor Immunity via MIF‐Induced Functional Orchestration of Tumor‐Associated Macrophages. Advanced Science. https://doi.org/10.1002/advs.202511330

Vancouver

He L, Peng Y, Leong LL, Zhou J, Tang D, Wang W, et al. CDK4/6 Inhibition Induces CD8 + T Cell Antitumor Immunity via MIF‐Induced Functional Orchestration of Tumor‐Associated Macrophages. Advanced Science. 2026. doi:10.1002/advs.202511330

BibTeX
@article{He2026,
  author = {He, Lin and Peng, Yuzhong and Leong, Lat-Lun and Zhou, Jingbo and Tang, Dongyang and Wang, Weilu and Wu, Xiaoran and Haipeng Lei, Josh and Ye, Yongqin and Feng, Yangyang and Qiao, Yunfeng and Chu, Xiangpeng and Mu, Di and Zhao, Qi and Liu, Tzuming and Chen, Yan and Tam, Paul Kwonghang and Deng, Chu-Xia},
  title = {CDK4/6 Inhibition Induces CD8 + T Cell Antitumor Immunity via MIF‐Induced Functional Orchestration of Tumor‐Associated Macrophages},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202511330}
}
Kostenlos starten →